Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
Intermittent preventive treatment with dihydroartemisinin-piperaquine (DP) is protective in children against malaria. Here, the authors analyze plasma drug concentration, malaria incidence, and drug resistance markers from a clinical trial in Uganda and determine the optimal DP dosing regimen.
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/eb16f6a003e14f9781c89f59d68e0072 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:doaj.org-article:eb16f6a003e14f9781c89f59d68e0072 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:eb16f6a003e14f9781c89f59d68e00722021-11-21T12:36:31ZIdentifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children10.1038/s41467-021-27051-82041-1723https://doaj.org/article/eb16f6a003e14f9781c89f59d68e00722021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-27051-8https://doaj.org/toc/2041-1723Intermittent preventive treatment with dihydroartemisinin-piperaquine (DP) is protective in children against malaria. Here, the authors analyze plasma drug concentration, malaria incidence, and drug resistance markers from a clinical trial in Uganda and determine the optimal DP dosing regimen.Erika WallenderAli Mohamed AliEmma HughesAbel KakuruPrasanna JagannathanMary Kakuru MuhindoBishop OpiraMeghan WhalenLiusheng HuangMarvin DuvalsaintJenny LegacMoses R. KamyaGrant DorseyFrancesca AweekaPhilip J. RosenthalRada M. SavicNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Erika Wallender Ali Mohamed Ali Emma Hughes Abel Kakuru Prasanna Jagannathan Mary Kakuru Muhindo Bishop Opira Meghan Whalen Liusheng Huang Marvin Duvalsaint Jenny Legac Moses R. Kamya Grant Dorsey Francesca Aweeka Philip J. Rosenthal Rada M. Savic Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children |
description |
Intermittent preventive treatment with dihydroartemisinin-piperaquine (DP) is protective in children against malaria. Here, the authors analyze plasma drug concentration, malaria incidence, and drug resistance markers from a clinical trial in Uganda and determine the optimal DP dosing regimen. |
format |
article |
author |
Erika Wallender Ali Mohamed Ali Emma Hughes Abel Kakuru Prasanna Jagannathan Mary Kakuru Muhindo Bishop Opira Meghan Whalen Liusheng Huang Marvin Duvalsaint Jenny Legac Moses R. Kamya Grant Dorsey Francesca Aweeka Philip J. Rosenthal Rada M. Savic |
author_facet |
Erika Wallender Ali Mohamed Ali Emma Hughes Abel Kakuru Prasanna Jagannathan Mary Kakuru Muhindo Bishop Opira Meghan Whalen Liusheng Huang Marvin Duvalsaint Jenny Legac Moses R. Kamya Grant Dorsey Francesca Aweeka Philip J. Rosenthal Rada M. Savic |
author_sort |
Erika Wallender |
title |
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children |
title_short |
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children |
title_full |
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children |
title_fullStr |
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children |
title_full_unstemmed |
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children |
title_sort |
identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young ugandan children |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/eb16f6a003e14f9781c89f59d68e0072 |
work_keys_str_mv |
AT erikawallender identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT alimohamedali identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT emmahughes identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT abelkakuru identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT prasannajagannathan identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT marykakurumuhindo identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT bishopopira identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT meghanwhalen identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT liushenghuang identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT marvinduvalsaint identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT jennylegac identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT mosesrkamya identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT grantdorsey identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT francescaaweeka identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT philipjrosenthal identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren AT radamsavic identifyinganoptimaldihydroartemisininpiperaquinedosingregimenformalariapreventioninyoungugandanchildren |
_version_ |
1718418920536276992 |